{"id":"https://openalex.org/W1990201100","doi":"https://doi.org/10.1158/1535-7163.targ-13-a120","title":"Abstract A120: A Phase Ib study of CC-486 (Oral Azacitidine) as a priming agent for carboplatin or NAB-paclitaxel in subjects with relapsed and refractory solid tumors.","display_name":"Abstract A120: A Phase Ib study of CC-486 (Oral Azacitidine) as a priming agent for carboplatin or NAB-paclitaxel in subjects with relapsed and refractory solid tumors.","publication_year":2013,"publication_date":"2013-11-01","ids":{"openalex":"https://openalex.org/W1990201100","doi":"https://doi.org/10.1158/1535-7163.targ-13-a120","mag":"1990201100"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.targ-13-a120","doi":"https://doi.org/10.1158/1535-7163.targ-13-a120","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-13-a120","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064953304","display_name":"Patricia Mucci LoRusso","orcid":"https://orcid.org/0000-0001-7144-036X","observed_orcids":["https://orcid.org/0000-0001-7144-036X"]},"institutions":[{"id":"https://openalex.org/I4210090317","display_name":"The Barbara Ann Karmanos Cancer Institute","ror":"https://ror.org/00ee40h97","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800590384","https://openalex.org/I4210090317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia LoRusso","raw_affiliation_strings":["1Karmanos Cancer Institute, Detroit, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Karmanos Cancer Institute, Detroit, MI","institution_ids":["https://openalex.org/I4210090317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073134832","display_name":"Drew Warren Rasco","orcid":"https://orcid.org/0009-0009-6619-2854","observed_orcids":["https://orcid.org/0009-0009-6619-2854"]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Drew Rasco","raw_affiliation_strings":["2South Texas Accelerated Research Therapeutics, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2South Texas Accelerated Research Therapeutics, San Antonio, TX","institution_ids":["https://openalex.org/I4210119066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028472820","display_name":"Johanna C. Bendell","orcid":"https://orcid.org/0000-0001-9426-5891","observed_orcids":["https://orcid.org/0000-0001-9426-5891"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Johanna Bendell","raw_affiliation_strings":["3Sarah Cannon Cancer Institute, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Sarah Cannon Cancer Institute, Nashville, TN","institution_ids":["https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055462512","display_name":"Jasgit C. Sachdev","orcid":"https://orcid.org/0000-0002-4408-7617","observed_orcids":["https://orcid.org/0000-0002-4408-7617"]},"institutions":[{"id":"https://openalex.org/I1284308235","display_name":"Translational Genomics Research Institute","ror":"https://ror.org/02hfpnk21","country_code":"US","type":"facility","lineage":["https://openalex.org/I1284308235"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jasgit Sachdev","raw_affiliation_strings":["4Translational Genomics Research Institute (TGen), Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Translational Genomics Research Institute (TGen), Scottsdale, AZ","institution_ids":["https://openalex.org/I1284308235"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113733729","display_name":"Ramesh K. Ramanathan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1284308235","display_name":"Translational Genomics Research Institute","ror":"https://ror.org/02hfpnk21","country_code":"US","type":"facility","lineage":["https://openalex.org/I1284308235"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ramesh Ramanathan","raw_affiliation_strings":["4Translational Genomics Research Institute (TGen), Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Translational Genomics Research Institute (TGen), Scottsdale, AZ","institution_ids":["https://openalex.org/I1284308235"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041612368","display_name":"G.J. Weiss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1284308235","display_name":"Translational Genomics Research Institute","ror":"https://ror.org/02hfpnk21","country_code":"US","type":"facility","lineage":["https://openalex.org/I1284308235"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Glenn Weiss","raw_affiliation_strings":["4Translational Genomics Research Institute (TGen), Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Translational Genomics Research Institute (TGen), Scottsdale, AZ","institution_ids":["https://openalex.org/I1284308235"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083373965","display_name":"Pamela N. M\u00fcnster","orcid":"https://orcid.org/0000-0002-2074-0984","observed_orcids":["https://orcid.org/0000-0002-2074-0984","https://orcid.org/0009-0009-4141-2312"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pamela Munster","raw_affiliation_strings":["5University of California, San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5University of California, San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006591586","display_name":"William Jeffery Edenfield","orcid":"https://orcid.org/0000-0001-8232-2318","observed_orcids":["https://orcid.org/0000-0001-8232-2318"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William J. Edenfield","raw_affiliation_strings":["6Caner Cancer of the Carolinas, Greenville, SC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Caner Cancer of the Carolinas, Greenville, SC","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073859762","display_name":"Kejian Liu","orcid":"https://orcid.org/0000-0002-4532-1583","observed_orcids":["https://orcid.org/0000-0002-4532-1583"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kejian Liu","raw_affiliation_strings":["7Celgene Corporation, Basking Ridge, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Celgene Corporation, Basking Ridge, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044166141","display_name":"Anne Blackwood\u2010Chirchir","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Blackwood-Chirchir","raw_affiliation_strings":["8Celgene Corporation, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Celgene Corporation, San Francisco, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001258905","display_name":"Jorge F. DiMartino","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jorge DiMartino","raw_affiliation_strings":["8Celgene Corporation, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Celgene Corporation, San Francisco, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001258905","display_name":"Jorge F. DiMartino","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jorge DiMartino","raw_affiliation_strings":["8Celgene Corporation, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Celgene Corporation, San Francisco, CA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080900202","display_name":"Daniel D. Von Hoff","orcid":"https://orcid.org/0000-0003-4723-7681","observed_orcids":["https://orcid.org/0000-0003-4723-7681"]},"institutions":[{"id":"https://openalex.org/I1284308235","display_name":"Translational Genomics Research Institute","ror":"https://ror.org/02hfpnk21","country_code":"US","type":"facility","lineage":["https://openalex.org/I1284308235"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel D. Von Hoff","raw_affiliation_strings":["4Translational Genomics Research Institute (TGen), Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Translational Genomics Research Institute (TGen), Scottsdale, AZ","institution_ids":["https://openalex.org/I1284308235"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"12","issue":"11_Supplement","first_page":"A120","last_page":"A120"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.7411999702453613,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.7411999702453613,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.08229999989271164,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.023000000044703484,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cc-486","display_name":"CC-486","score":0.9599999785423279},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.8820000290870667},{"id":"https://openalex.org/keywords/nab-paclitaxel","display_name":"nab-paclitaxel","score":0.9419999718666077},{"id":"https://openalex.org/keywords/priming-agents","display_name":"priming agents","score":0.5339999794960022},{"id":"https://openalex.org/keywords/relapsed-solid-tumors","display_name":"relapsed solid tumors","score":0.7390000224113464},{"id":"https://openalex.org/keywords/refractory-solid-tumors","display_name":"refractory solid tumors","score":0.906000018119812},{"id":"https://openalex.org/keywords/dna-methylation","display_name":"DNA methylation","score":0.6389999985694885},{"id":"https://openalex.org/keywords/global-hypomethylation","display_name":"global hypomethylation","score":0.7099999785423279},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7170000076293945},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.800000011920929},{"id":"https://openalex.org/keywords/pericardial-effusion","display_name":"pericardial effusion","score":0.8379999995231628},{"id":"https://openalex.org/keywords/recommended-phase-ii-dose","display_name":"recommended phase 2 dose","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8656424283981323},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.7926656007766724},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7781388759613037},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.611753523349762},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6094757914543152},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5793195366859436},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5152173638343811},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.49838852882385254},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.4786444902420044},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.4780421853065491},{"id":"https://openalex.org/C2780873365","wikidata":"https://www.wikidata.org/wiki/Q496812","display_name":"Leukopenia","level":3,"score":0.44283202290534973},{"id":"https://openalex.org/C2776012956","wikidata":"https://www.wikidata.org/wiki/Q17125294","display_name":"Hypomethylating agent","level":5,"score":0.4403858184814453},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2946954369544983},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.19892126321792603},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.targ-13-a120","doi":"https://doi.org/10.1158/1535-7163.targ-13-a120","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-13-a120","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.8100000023841858,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1975956559","https://openalex.org/W2145911819","https://openalex.org/W4229800691","https://openalex.org/W111200021","https://openalex.org/W4307628892","https://openalex.org/W2419266003","https://openalex.org/W2888771996","https://openalex.org/W2396974074","https://openalex.org/W2623478857","https://openalex.org/W1990201100"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"CC-486,":[2],"an":[3],"oral":[4],"formulation":[5],"of":[6,20,66,91,117,131,137,157,193,219,234,252,298,345,353,421,444],"5-azacitidine,":[7],"induces":[8],"global":[9],"genomic":[10],"hypomethylation":[11,259],"and":[12,23,125,153,183,210,247,267,296,319,339,361,376,437,451],"clinical":[13,346],"responses":[14],"in":[15,57,135,241,260,264,276,315,322,433],"MDS":[16],"patients":[17,58,69],"at":[18,169,195,255,289,350],"doses":[19,156],"200":[21,123,151,197,217,293,320],"mg":[22,124,127,152,155,172,198,218,291,309,321],"300":[24,126,154,171,225,290,308],"mg/day":[25],"for":[26,52,429],"14":[27,83,106],"or":[28,54,99,358,366,431],"21/28":[29],"days":[30,80,103,208,330],"with":[31,59,70,84,107,221,231,270,317,324,337,435],"acceptable":[32],"safety.":[33],"This":[34],"non-randomized,":[35],"multi-center":[36],"Phase":[37,418],"Ib":[38,419],"study":[39,420],"was":[40,162,202,229,287,310],"designed":[41],"to":[42,76,139,204,371],"determine":[43],"whether":[44],"CC-486":[45,79,102,132,158,220,279,327,422],"can":[46],"be":[47],"delivered":[48],"safely":[49],"as":[50,312,333,425],"priming":[51,335,427],"carboplatin":[53,85,318,338,430],"NAB-Paclitaxel":[55],"(ABI-007)":[56],"solid":[60,72,439],"tumors.":[61,440],"Methods:":[62],"In":[63],"Part":[64,143],"1":[65,81,104,119],"this":[67],"study,":[68],"refractory":[71,438],"tumors":[73],"were":[74,133,159,190,214],"assigned":[75],"Arm":[77,100,149,187,242,265,277,354,362],"A:":[78],"-":[82,105],"AUC":[86],"4":[87,274],"on":[88,114,207,216],"day":[89,94],"8":[90,116,209],"a":[92,141,334,426],"21":[93],"cycle":[95],"(n":[96,120],"=":[97,121],"13)":[98],"B:":[101],"ABI-007":[108,206],"100":[109],"mg/m2":[110],"given":[111],"weekly":[112],"starting":[113],"Day":[115],"Cycle":[118],"24).":[122],"dose":[128,145],"levels":[129],"(DLs)":[130],"evaluated":[134],"cohorts":[136,349],"6":[138],"identify":[140],"recommended":[142],"2":[144,191,232,306],"(RP2D).":[146],"Results:":[147],"On":[148,186],"A,":[150],"tolerated.":[160],"There":[161],"one":[163],"DLT":[164],"(Grade":[165],"3":[166,262],"pericardial":[167],"effusion)":[168],"the":[170,196,227,305,313,351,445],"DL.":[173,199],"Other":[174,238],"related":[175],"treatment-emergent":[176],"adverse":[177],"events":[178],"(TEAEs)":[179],"included":[180,244,258],"anemia":[181],"(53.8%)":[182],"neutropenia":[184,194,235],"(46.3%).":[185],"B,":[188],"there":[189],"DLTs":[192,213,233],"The":[200],"protocol":[201],"amended":[203],"give":[205],"15/21.":[211],"No":[212],"encountered":[215],"intermittent":[222],"ABI-007.":[223,325,340],"At":[224],"mg,":[226],"MTD":[228],"exceeded":[230],"(cholangiocarcinoma,":[236],"pancreatic).":[237],"common":[239],"TEAEs":[240],"B":[243,266,363],"nausea/vomiting":[245],"(45.8%)":[246],"peripheral":[248],"neuropathy":[249],"(50%).":[250],"Evidence":[251],"activity":[253],"seen":[254],"both":[256],"DLs":[257],"PBMCs,":[261],"PRs":[263],"5":[268],"subjects":[269,434],"stable":[271],"disease":[272],"(>":[273],"mos)":[275],"A.":[278],"plasma":[280],"exposure":[281],"showed":[282],"high":[283],"interpatient":[284],"variability":[285],"but":[286],"higher":[288],"than":[292],"mg.":[294],"Incidence":[295],"severity":[297],"AEs":[299],"did":[300],"not":[301],"differ":[302],"significantly":[303],"between":[304],"DLs.":[307],"selected":[311],"RP2D":[314,352],"combination":[316,323],"Conclusion:":[326],"dosed":[328],"14/21":[329],"is":[331],"tolerated":[332],"agent":[336,428],"Both":[341],"combinations":[342],"show":[343],"evidence":[344],"activity.":[347,378],"Expansion":[348],"A":[355,417],"(relapsed/refractory":[356,364],"bladder":[357],"ovarian":[359],"carcinoma)":[360,368],"NSCLC":[365],"pancreatic":[367],"are":[369],"enrolling":[370],"further":[372],"characterize":[373],"safety,":[374],"PK/PD":[375],"anti-tumor":[377],"Citation":[379,386],"Information:":[380],"Mol":[381,462],"Cancer":[382,452,463],"Ther":[383,464],"2013;12(11":[384,465],"Suppl):A120.":[385],"Format:":[387],"Patricia":[388],"LoRusso,":[389],"Drew":[390],"Rasco,":[391],"Johanna":[392],"Bendell,":[393],"Jasgit":[394],"Sachdev,":[395],"Ramesh":[396],"Ramanathan,":[397],"Glenn":[398],"Weiss,":[399],"Pamela":[400],"Munster,":[401],"William":[402],"J.":[403],"Edenfield,":[404],"Kejian":[405],"Liu,":[406],"Anne":[407],"Blackwood-Chirchir,":[408],"Jorge":[409,411],"DiMartino,":[410,412],"Daniel":[413],"D.":[414],"Von":[415],"Hoff.":[416],"(Oral":[423],"Azacitidine)":[424],"NAB-paclitaxel":[432],"relapsed":[436],"[abstract].":[441],"In:":[442],"Proceedings":[443],"AACR-NCI-EORTC":[446],"International":[447],"Conference:":[448],"Molecular":[449],"Targets":[450],"Therapeutics;":[453],"2013":[454],"Oct":[455],"19-23;":[456],"Boston,":[457],"MA.":[458],"Philadelphia":[459],"(PA):":[460],"AACR;":[461],"Suppl):Abstract":[466],"nr":[467],"A120.":[468]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2025-10-10T00:00:00"}